Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Soellner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Angewandte Chemie (International Ed. in English)|October 25, 2022
Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Taylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2021
Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine KinaseTaylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
ACS Chemical Biology|July 10, 2019
Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src KinaseMichael P Agius, Kristin S Ko, Taylor K Johnson, et al.
RSC Medicinal Chemistry|February 28, 2022
Insights into the modular design of kinase inhibitors and application to Abl and AxlSameer Phadke, Lluis Lopez-Barcons, Nathalie Vandecan, et al.
Frontiers in Oncology|June 20, 2019
IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 SignalingAndrew C Little, Pragathi Pathanjeli, Zhifen Wu, et al.
Oncotarget|November 20, 2020
MEK is a promising target in the basal subtype of bladder cancerNathan M Merrill, Nathalie M Vandecan, Kathleen C Day, et al.
ACS Chemical Biology|December 19, 2023
Selective and Potent PROTAC Degraders of c-Src KinaseWuxiang Mao, Nathalie M Vandecan, Christopher R Bingham, et al.
ACS Chemical Biology|February 20, 2016
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and SelectivityFrank E Kwarcinski, Kristoffer R Brandvold, Sameer Phadke, et al.
Breast Cancer Research and Treatment|October 28, 2019
Molecular determinants of drug response in TNBC cell linesNathan M Merrill, Eric J Lachacz, Nathalie M Vandecan, et al.
NPJ Breast Cancer|June 10, 2024
Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasionHabib A Serhan, Liwei Bao, Xu Cheng, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Angewandte Chemie (International Ed. in English)|October 25, 2022
Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Taylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2021
Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine KinaseTaylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
ACS Chemical Biology|July 10, 2019
Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src KinaseMichael P Agius, Kristin S Ko, Taylor K Johnson, et al.
RSC Medicinal Chemistry|February 28, 2022
Insights into the modular design of kinase inhibitors and application to Abl and AxlSameer Phadke, Lluis Lopez-Barcons, Nathalie Vandecan, et al.
Frontiers in Oncology|June 20, 2019
IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 SignalingAndrew C Little, Pragathi Pathanjeli, Zhifen Wu, et al.
Oncotarget|November 20, 2020
MEK is a promising target in the basal subtype of bladder cancerNathan M Merrill, Nathalie M Vandecan, Kathleen C Day, et al.
ACS Chemical Biology|December 19, 2023
Selective and Potent PROTAC Degraders of c-Src KinaseWuxiang Mao, Nathalie M Vandecan, Christopher R Bingham, et al.
ACS Chemical Biology|February 20, 2016
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and SelectivityFrank E Kwarcinski, Kristoffer R Brandvold, Sameer Phadke, et al.
Breast Cancer Research and Treatment|October 28, 2019
Molecular determinants of drug response in TNBC cell linesNathan M Merrill, Eric J Lachacz, Nathalie M Vandecan, et al.
NPJ Breast Cancer|June 10, 2024
Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasionHabib A Serhan, Liwei Bao, Xu Cheng, et al.
Pageof 5